• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Technology Bio Tech

Oneview Shares Rise 7% as It Signs a Key Five-Year Deal (ASX:ONE)

Like 0

By Ryan Clarkson-Ledward, Wednesday, 20 October 2021

Tiny medtech stock Oneview Healthcare PLC [ASX:ONE] is on the up today. The ONE share price currently trading 6.98% higher at time of writing, paring back earlier gains of as much as 20.9% today.

Tiny medtech stock Oneview Healthcare PLC [ASX:ONE] is on the up today.

The ONE share price currently trading 6.98% higher at time of writing, paring back earlier gains of as much as 20.9% today.

A sign that investors have clearly welcomed the announcement of a new five-year deal for the company. And perhaps caused a few to take some profits off the table.

Let’s take a closer look at deal itself…

Five-year contract with a notable provider

As already mentioned, with a five-year contract length, this deal is a long-term one.

But more impressively, it is a long-term contract with a large healthcare provider — signing on Kingman Regional Medical Center (KRMC) in northwest Arizona. This is the first customer under Onehealth’s co-sell program in conjunction with Microsoft.

With 235 beds, 1,900 staff, and 270 physicians/allied health professionals, KRMC is the largest healthcare provider in the region. Making this a huge win for Oneview and their ongoing objective to win market share in the US.

With their CXP Cloud Enterprise product, their goal is to reduce the burden on large institutions like KRMC. Delivering world-class care to patients, whilst also optimising clinical and operational abilities.

As Oneview’s Vice President of Sales comments:

‘We are delighted to welcome Kingman to our global list of customer partnerships. We have been very impressed by the vision and innovation Kingman wishes to bring to their community.

‘The Cloud CXP offering will help Kingman deliver on their digital transformation strategy and establish a platform for innovation. The system is due to commence deployment in December, just months after contract signing, reinforcing the importance of Cloud for agility and speed to value.’

How to Limit Your Risks While Trading Volatile Stocks. Learn more.

What’s next for the Oneview Share Price?

Looking ahead, the focus now for Oneview is naturally to build upon this momentum — looking for further contracts and partnerships to extend their reach and offering to US healthcare providers.

Thankfully, this deal should help solidify their offering. An endorsement that may help them win over even more clients.

And for shareholders, that will be the key thing to look out for in the months to come.

However, while Oneview is certainly stealing the limelight today, there are plenty of other tiny stocks that go unnoticed. Companies that have the potential to deliver equally impressive results but are overlooked by the masses.

As such, there are some fantastic opportunities to be found in the small-cap space. And in our latest report, we’ve put together a list of four that we think you should know about. A collection of stocks that could be ready to break out…

For all the details, including the names of these four stocks, check out the full report, right here.

Regards,

Ryan Clarkson-Ledward,
For Money Morning

PS: Our publication Money Morning is a fantastic place to start on your investment journey. We talk about the big trends driving the most innovative stocks on the ASX. Learn all about it here

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Ryan Clarkson-Ledward

Ryan’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • Lion Clock says buy now for the big pay off later
    By Callum Newman

    Now is the time to be investing and following into this sector. According to the Lion investment clock, now’s the time to scoop up what you can and surf the rising liquidity wave.

  • Cashflow Gems: Focus on Mining Juniors That Own the Golden Goose
    By James Cooper

    Exploration success hinges on continuous drilling, and self-funding juniors have the edge. Discover how these companies leverage cash flow to advance projects without pausing, while their cash-strapped competitors face hibernation.

  • Tick, tock: there’s a boom brewing in one sector…
    By Callum Newman

    All the old hands say you’re supposed to buy resources when they’re down in the dumps. That’s the theory. It’s the timing that’s the bitch. Here’s some help with that…

Primary Sidebar

Latest Articles

  • Lion Clock says buy now for the big pay off later
  • Cashflow Gems: Focus on Mining Juniors That Own the Golden Goose
  • Tick, tock: there’s a boom brewing in one sector…
  • Buy oil when there’s peace in the streets
  • Vicuña: The Greatest Mineral Discovery of Our Lifetime

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988